CANbridge Pharmaceuticals Inc. (1228.HK)
HKD 0.16
(0.65%)
HKD 0.16
(0.65%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.89 CNY | 21.93% |
| 2022 | -1.14 CNY | 90.03% |
| 2021 | -11.43 CNY | -474.37% |
| 2020 | -1.99 CNY | -290.2% |
| 2019 | -0.51 CNY | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.29 CNY | 0.0% |
| 2024 Q1 | -0.29 CNY | -52.63% |
| 2023 Q3 | -0.19 HKD | 26.92% |
| 2023 FY | - CNY | 21.93% |
| 2023 Q2 | -0.26 CNY | 0.0% |
| 2023 Q1 | -0.26 CNY | 7.14% |
| 2023 Q4 | -0.19 CNY | 0.0% |
| 2022 Q2 | -0.29 CNY | 0.0% |
| 2022 Q1 | -0.29 CNY | 90.91% |
| 2022 FY | - CNY | 90.03% |
| 2022 Q4 | -0.28 CNY | 0.0% |
| 2022 Q3 | -0.28 CNY | 3.45% |
| 2021 Q1 | -1.53 CNY | 69.52% |
| 2021 FY | - CNY | -474.37% |
| 2021 Q4 | -3.19 CNY | 0.0% |
| 2021 Q3 | -3.19 CNY | -1.27% |
| 2021 Q2 | -3.15 CNY | -105.88% |
| 2020 Q4 | -5.02 CNY | 0.0% |
| 2020 Q2 | -0.38 CNY | 80.07% |
| 2020 Q3 | -5.02 CNY | -1221.05% |
| 2020 Q1 | -1.91 CNY | 0.0% |
| 2020 FY | - CNY | -290.2% |
| 2019 FY | - CNY | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 0.01 HKD | 8118.018% |
| CK Life Sciences Int'l., (Holdings) Inc. | 0.00 HKD | 49544.444% |